Philippine News Agency
New guidelines on AstraZeneca vax use out this week: FDA
The Food and Drug Administration (FDA) is expected to release new guidelines this week for the administration of the AstraZeneca COVID-19 vaccine.
These new guidelines come after the FDA and Department of Health temporarily suspended the use of the vaccine for individuals aged 59 and below.
The suspension was a precautionary measure following findings by the European Medicines Agency (EMA) of a very rare side effect of blood clotting associated with the vaccine.
Despite the rare side effect, the World Health Organization (WHO) and other expert panels have concluded that the benefits of the AstraZeneca vaccine outweigh the risks.
The upcoming guidelines will instruct healthcare providers on how to properly advise vaccine recipients about potential symptoms to watch for regarding the rare blood clotting event.
Topics in this story
Explore more stories about these topics.
🤖
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
News Sources
See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.
The Food and Drug Administration (FDA) will release new guidance on the AstraZeneca vaccine this week following a temporary suspension for those under 60 due to concerns about rare blood clots.
Read more →
The Philippines' Department of Health (DOH) announced the resumption of AstraZeneca COVID-19 vaccinations for individuals under 60 years old.
+1
Read more →
The Philippines has temporarily suspended the use of AstraZeneca's COVID-19 vaccine for individuals under 60 years old as a precautionary measure due to rare reports of blood clots with low platelet counts overseas, primarily observed in women under 60.
+2
Read more →